SCHEMBL15744773

SCHEMBL15744773

CC(=O)c1ccc(C(=O)NC2CCN(Cc3ccc(O)cc3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.62
▸ MEN1 O00255 2/20 0.62
▸ SIGMAR1 Q99720 3/20 0.61
▸ TMEM97 Q5BJF2 3/20 0.61
▸ MCHR1 Q99705 2/20 0.61
▸ SLC6A12 P48065 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2D6 P10635 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ KDM4E B2RXH2 1/20 0.59
▸ KCNH2 Q12809 1/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ LMNA P02545 1/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ DRD4 P21917 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15745866 0.88 MEN1 (0.60) KMT2AMEN1SIGMAR1TMEM97MCHR1
SCHEMBL14649115 0.86 PRKAA2 (0.66) KMT2AMEN1SIGMAR1TMEM97MCHR1
SCHEMBL12642632 0.85 SIGMAR1 (0.59) KMT2AMEN1SIGMAR1TMEM97MCHR1
SCHEMBL61848 0.82 TMEM97 (0.83) KMT2AMEN1SIGMAR1TMEM97MCHR1
SCHEMBL14100464 0.79 SIGMAR1 (0.64) KMT2ASIGMAR1MCHR1KDM4EDRD4
SCHEMBL12642482 0.79 SIGMAR1 (0.72) SIGMAR1
SCHEMBL14115981 0.79 SIGMAR1 (0.67) KMT2ASIGMAR1KCNH2DRD4
SCHEMBL694949 0.79 SIGMAR1 (0.82) KMT2AMEN1SIGMAR1TMEM97MCHR1
SCHEMBL8274001 0.79 MEN1 (0.78) KMT2AMEN1SIGMAR1TMEM97MCHR1
SCHEMBL4240454 0.78 CCR3 (0.59) MCHR1DRD4CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871770-B2 Carboxamide compounds and methods for using the same MIDCAP FINANCIAL TRUST 2014-10-28 — — US disclosed
US-20140148467-A1 Carboxamide Compounds and Methods for Using the Same RIGEL PHARMACEUTICALS, INC. (US) 2014-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148467-A1 Carboxamide Compounds and Methods for Using the Same PC, AK2, PRKAA2 KMT2A 324/4885MEN1 3205/4885SIGMAR1 2015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback